FIELD: medicine, otorhinolaryngology. SUBSTANCE: invention proposes the composition containing ciprofloxacine and method of its preparing. Composition has from 0.12 to 0.6 g/ml of ciprofloxacine chlorohydrate monohydrate (this value is equivalent to 0.1-0.5% of free base); 0.05-0.3 g/ml of nonionic surface-active substance; from 0.5 to 2.0 g/ml of thickening agent and water up to 100 ml. Method of preparing involves the dispersion of thickening agent at heating, addition of surface-active substance, acetic acid, sodium acetate solution and ciprofloxacine and pH value is brought about to 4.5-4.9. Composition has no preserving agents and exhibits stability. EFFECT: improved method of preparing. 11 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS AND METHOD FOR THEIR OBTAINING | 2003 |
|
RU2248199C1 |
THERAPEUTIC COMPOSITION FOR THE TREATMENT OF OTITIS MEDIA WITH PERFORATION OF THE TYMPANIC MEMBRANE | 2022 |
|
RU2782926C1 |
METHOD FOR TREATING MIDDLE EAR INFECTION CASES | 2002 |
|
RU2295346C2 |
AQUEOUS TRANSPARENT SOLUTIONS OF FLUOCINOLONE ACETONIDE FOR TREATMENT OF EAR INFLAMMATION | 2011 |
|
RU2549465C2 |
CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION | 2018 |
|
RU2759901C2 |
COMPOSITION AND METHOD FOR PREPARING CIPROFLOXACIN OPHTHALMIC OINTMENT | 2006 |
|
RU2317810C1 |
PAZOPANIB COMPOSITION | 2012 |
|
RU2616500C2 |
FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
COMPOSITION CONTAINING FIXED DOSE OF ANGIOTENSIN-TRANSFORMING ENZYME AND CALCIUM CANAL ANTAGONIST AND METHOD FOR PRODUCING THE COMPOSITION AND TREATING CARDIOVASCULAR DISEASES | 1998 |
|
RU2182002C2 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
Authors
Dates
2001-04-27—Published
1996-07-26—Filed